Sub-category 3.4 - Antihistamines, hyposensitisation and allergic emergencies
Grazax
New Drug Evaluation
83
Apr 07
Omalizumab (N)
75
May 06
Omalizumab in severe persistent allergic asthma (N)
Evaluation report
Jun 06
Home | About us | Management | Publications | Education | Services | Links | Contact us | Search
RSS Feed
Site last updated 03/02/2012